Our immune system is designed to protect us. Every day, special cells travel through our bodies searching for bacteria, viruses, and abnormal cells that could make us sick. When these cells find a threat, they quickly attack and destroy it. This powerful defense system is one of the main reasons our bodies are able to survive infections and stay healthy.
However, sometimes the immune system can go wrong. Instead of protecting the body, it may begin attacking healthy tissues.
When this happens, it can lead to autoimmune diseases such as rheumatoid arthritis, lupus, or aplastic anemia. Scientists have long wondered why this happens and why some people with blood cancers like leukemia often develop autoimmune problems at the same time.
Now researchers at the Garvan Institute of Medical Research in Australia have discovered an important clue. Their new study shows that certain genetic changes linked to leukemia can also create abnormal immune cells that attack the body.
These “rogue” immune cells may help explain why cancer and autoimmune diseases sometimes appear together in the same patient.
In a healthy immune system, a group of cells called T cells plays a very important role. T cells are a type of white blood cell. Some of them are known as “killer T cells.” These cells act like soldiers. They move around the body looking for infected cells or cancer cells. When they find something dangerous, they destroy it to keep the body safe.
But the researchers found that certain genetic mutations can cause these killer T cells to behave in an unusual and dangerous way. Instead of stopping after doing their job, the cells continue growing and multiplying. Even worse, they may begin attacking the body’s own healthy cells.
When the immune system starts damaging healthy tissues, autoimmune diseases can develop. These conditions can affect many parts of the body, including the joints, bone marrow, skin, and organs. Doctors have noticed that some patients with leukemia often experience autoimmune conditions, but until recently it was not clear exactly why this happens.
To understand the problem better, the scientists studied blood samples from children who had rare inherited autoimmune diseases. These rare conditions gave the researchers a chance to see how genetic changes can affect the immune system from an early age.
The research team also used a powerful gene editing tool called CRISPR-Cas9. This technology allows scientists to change genes in a very precise way. By using CRISPR in mice, the researchers could observe how certain genetic mutations affect immune cells and how those changes might lead to disease.
The scientists focused on a protein called STAT3. This protein plays an important role in controlling how immune cells grow, divide, and respond to signals from the body. Normally, STAT3 helps maintain balance in the immune system.
However, the study found that when the STAT3 gene is altered, the immune system can lose this balance. Killer T cells with this mutation become larger and more active than normal cells. They also stop responding to the signals that usually control immune activity.
This means the cells no longer follow the normal rules that keep the immune system in check. Instead, they begin behaving in ways that can damage the body.
One of the most surprising findings from the research was that only a very small number of these abnormal cells is needed to cause serious problems. The study showed that rogue T cells made up only about one to two percent of all immune cells. Even with such a small presence, they were still able to trigger major autoimmune diseases.
This discovery is important because it shows how a tiny change in the immune system can have a large impact on health. It also helps explain why autoimmune diseases sometimes appear in patients with blood cancers like leukemia.
The researchers believe their findings could lead to better treatments in the future. Some medicines that target immune signals already exist. For example, drugs known as JAK inhibitors are used to treat several inflammatory diseases. These medicines are already approved in Australia by the Therapeutic Goods Administration.
With the new understanding of how genes such as STAT3 affect immune cells, doctors may be able to use these medicines in a more targeted way. In the future, treatments could be chosen based on a patient’s genetic profile, making them more effective.
The team also discovered new details about two groups of cell receptors that help immune cells respond to stress signals in the body. These receptors allow immune cells to communicate with each other. Understanding how they work could help scientists find new ways to stop dangerous immune cells before they cause damage.
Another possible benefit of this research is improved diagnosis. In the future, advanced blood tests may allow doctors to examine the immune system at a very detailed genetic level. Such tests could help detect abnormal immune cells early, long before symptoms of autoimmune disease begin.
The study was led by Dr. Etienne Masle-Farquhar and was published in the scientific journal Immunity. The findings provide an important step toward understanding the connection between leukemia and autoimmune diseases.
By uncovering how small genetic changes can turn protective immune cells into harmful ones, scientists hope to develop better ways to prevent, diagnose, and treat these serious conditions.
If you care about inflammation, please read studies about turmeric: nature’s golden answer to inflammation, and what to eat to reduce chronic Inflammation.
For more health information, please see recent studies about how a plant-based diet could help ease inflammation, and Vitamin D deficiency linked to increased inflammation.
Copyright © 2026 Knowridge Science Report. All rights reserved.
